Advances in stroke medicine

Cheng, Suk; Richards, Toby

doi:10.5694/mja2.50431

Topics

Nervous system diseases

Hematologic diseases

Vascular diseases

Diagnostic techniques and procedures

Cardiovascular diseases

To the Editor: Reperfusion therapies in acute ischaemic stroke have become well recognised in recent years. The article by Campbell1 summarises current practice and addresses the benefits and challenges of several reperfusion therapies, but it misses one key prevention strategy.

1 University College London, London, UK
2 University of Western Australia, Perth, WA

Correspondence: amanda.cheng@nhs.net

Competing interests:

No relevant disclosures.

1. Campbell BC. Advances in stroke medicine. Med J Aust 2019; 210: 367–374. https://www.mja.com.au/journal/2019/210/8/advances-stroke-medicine
2. Cheng SF, Brown MM, Simister RJ, Richards T. Contemporary prevalence of carotid stenosis in patients presenting with ischaemic stroke. Br J Surg 2019; 106: 872–878.
3. Momjian‐Mayor I, Baron JC. The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke 2005; 36: 567–577.
4. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55: 1475–1482.
5. Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2017; (6): CD001081.

Online responses are no longer available. Please refer to our instructions for authors page for more information.